Finch Therapeutics Group Inc (FNCH)
2.30
-0.19
(-7.63%)
USD |
NASDAQ |
May 03, 16:00
2.36
+0.06
(+2.61%)
After-Hours: 20:00
Finch Therapeutics Group Cash and Short Term Investments (Quarterly): 25.12M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.12M |
| September 30, 2023 | 28.78M |
| June 30, 2023 | 34.05M |
| March 31, 2023 | 41.68M |
| December 31, 2022 | 71.04M |
| September 30, 2022 | 85.29M |
| June 30, 2022 | 104.67M |
| Date | Value |
|---|---|
| March 31, 2022 | 106.93M |
| December 31, 2021 | 133.48M |
| September 30, 2021 | 149.20M |
| June 30, 2021 | 168.14M |
| March 31, 2021 | 193.02M |
| December 31, 2020 | 99.71M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
25.12M
Minimum
Dec 2023
193.02M
Maximum
Mar 2021
95.47M
Average
99.71M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 438.86M |
| Vanda Pharmaceuticals Inc | 388.26M |
| Sage Therapeutics Inc | 717.01M |
| BioSig Technologies Inc | 0.293M |
| Palisade Bio Inc | 12.43M |